QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Iron (total)
Iron (free) (Matrix: Human Serum)
Iron (free) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 2.00-5,000 ng/mL 2.00-150 ng/mL above native |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Drug Assays |
Isoniazid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 -4000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Sodium Heaprin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Isosorbide
Mononitrate (Matrix: Human Plasma)
Mononitrate (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 4,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Itraconazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antifungal |
| Classification: | Drug Assays |
Itraconazole
Hydroxyl-Itraconazole (Matrix: Human Plasma)
Hydroxyl-Itraconazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 500 ng/mL 2 – 1,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antifungal |
| Classification: | Drug Assays |
Ketoconazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antifungal |
| Classification: | Drug Assays |
Ketoprofen (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50.0 – 15,000 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | HPLC-UV |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Ketorolac (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 4,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Kidney injury molecule 1 (KIM-1) (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 0.156 – 10.0 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Kidney injury molecule 1 (KIM-1) (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 50.0 – 2,000 pg/mL |
| Sample Volume: | 0.125 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
KRAS (35G>T, 35G>A, 34G>T, 34G>A, 38G>A) (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N/A |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | |
| Therapy Area: | |
| Classification: | Genomic Biomarkers |
Lacosamide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 40 – 12,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anticonvulsant |
| Classification: | Genomic Biomarkers |
Lamivudine (3TC) Tenofovir (TFV) in presence of Dolutegravir (DTG), Efavirenz (EFV), and Emtricitabine (FTC) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 15 – 6,000 ng/mL 2.5 – 1,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Lamivudine (3TC)
Tenofovir (TFV) (Matrix: Human Plasma)
Tenofovir (TFV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 15 – 5,000 ng/mL 2 – 650 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Lamivudine (3TC)
Zalcitabine (ddC) (Matrix: Human Plasma)
Zalcitabine (ddC) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Lamotrigine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 600 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Anticonvulsant |
| Classification: | Drug Assays |
Lamotrigine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 2,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anticonvulsant |
| Classification: | Drug Assays |
Lamotrigine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 4,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anticonvulsant |
| Classification: | Drug Assays |
Lamotrigine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 3,500 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anticonvulsant |
| Classification: | Drug Assays |
Lamotrigine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 1,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Anticonvulsant |
| Classification: | Drug Assays |
Lansoprazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 2,250 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Gastrointestinal |
| Classification: | Drug Assays |
Lansoprazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 2,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Gastrointestinal |
| Classification: | Drug Assays |
Lapatinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 100 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Lenvatinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 400 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Leptin (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 15 – 1,000 pg/mL |
| Sample Volume: | 0.050 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
